Ajanta Pharma P/B Ratio

Current P/B Ratio
8.45
High Valuation
Very High - Significant premium, high growth expectations or speculative

Ajanta Pharma P/B ratio. Ajanta Pharma (AJANTPHARM) P/B ratio is 8.45 (High), book value per share ₹1810.80 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see AJANTPHARM stock price BSE.

Current Valuation Metrics

P/B Ratio 8.45
Current Price ₹3270.30
Book Value/Share ₹1810.80
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹4,527 Cr
Share Capital ₹25 Cr
Reserves & Surplus ₹4,502 Cr
Outstanding Shares 25,000,000
Book Value per Share ₹1810.80

Valuation Signal

Signal Overvalued
Historical Avg 1.57
Historical Range 0.63 - 2.06
Percentile 100.0%

Sector Context

Sector Average -0.3
Sector Median 0.39
Sector Rank #11 of 50
Sector Percentile 22.0%

AJANTPHARM P/B Ratio — Valuation Insights & Book Value Analysis

Ajanta Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 8.45 (High). Browse AJANTPHARM annual financials for revenue, profit, balance sheet and cash flow data.

  • Stock appears overvalued with PB of 8.45, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 436.8% above historical average
  • Trading at premium to sector average PB of -0.3

Ajanta Pharma P/B Ratio Historical Trend

AJANTPHARM annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read AJANTPHARM ex-dividend dates for the complete payout history and dividend yield track record.

AJANTPHARM Historical P/B Ratio — Book Value Per Share & Year-End Price

Ajanta Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 1.81 ₹1810.8 ₹3270.30 ₹4,527 Moderate
2025 1.83 ₹1516.0 ₹2768.90 ₹3,790 Moderate
2024 2.06 ₹1426.8 ₹2932.20 ₹3,567 Moderate
2023 1.54 ₹1355.2 ₹2083.65 ₹3,388 Moderate
2022 0.63 ₹1920.0 ₹1211.95 ₹3,264 Low

AJANTPHARM vs Healthcare Peers — P/B Ratio Comparison

Ajanta Pharma P/B 8.45 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.

Sector Average
-0.3
Sector Median
0.39
Lowest P/B
-7.62
Highest P/B
0.89
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Chennai Meenakshi Multis… CMMHOSP -7.62 ₹27 Low
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -1.2 ₹39 Low
Krebs Biochemicals & Ind… KREBSBIO -0.75 ₹128 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.18 ₹43 Low